These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34769209)

  • 1. Tailored Systemic Therapy for Colorectal Cancer Liver Metastases.
    Czauderna C; Luley K; von Bubnoff N; Marquardt JU
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study.
    Gibbs P; Gebski V; Van Buskirk M; Thurston K; Cade DN; Van Hazel GA;
    BMC Cancer; 2014 Dec; 14():897. PubMed ID: 25487708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HEMIHEPATECTOMY FOR RESECTABLE HEPATIC METASTASIS FROM COLORECTAL CANCER WITH POOR PROGNOSIS].
    Patyutko YI; Kotelnikov AG; Mamontov KG; Podluzhny DV; Ponomarenko AA
    Vopr Onkol; 2015; 61(3):439-47. PubMed ID: 26242159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating systemic and surgical approaches to treating metastatic colorectal cancer.
    Mi K; Kalady MF; Quintini C; Khorana AA
    Surg Oncol Clin N Am; 2015 Jan; 24(1):199-214. PubMed ID: 25444476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal treatment strategies for colorectal liver metastases.
    Birrer DL; Tschuor C; Reiner C; Fritsch R; Pfammatter T; Garcia Schüler H; Pavic M; De Oliveira M; Petrowsky H; Dutkowski P; Oberkofler C; Clavien PA
    Swiss Med Wkly; 2021 Feb; 151():w20390. PubMed ID: 33631027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of colorectal liver metastases].
    Folprecht G
    Dtsch Med Wochenschr; 2013 Oct; 138(41):2098-103. PubMed ID: 24085366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of transarterial chemoembolization combined with systemic chemotherapy for patients with KRAS wild-type unresectable metachronous colorectal carcinoma with liver metastases.
    Yu Q; Zhang L; Fan S; Huang L; Wang X; Xindun C
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C205-C211. PubMed ID: 28230018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
    Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-directed therapies in colorectal cancer.
    Alsina J; Choti MA
    Semin Oncol; 2011 Aug; 38(4):561-7. PubMed ID: 21810515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Management of Liver Metastases From Colorectal Cancer.
    Dhir M; Sasson AR
    J Oncol Pract; 2016 Jan; 12(1):33-9. PubMed ID: 26759464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study.
    Ruers TJ; Joosten JJ; Wiering B; Langenhoff BS; Dekker HM; Wobbes T; Oyen WJ; Krabbe PF; Punt CJ
    Ann Surg Oncol; 2007 Mar; 14(3):1161-9. PubMed ID: 17195903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial systemic chemotherapeutic and targeted therapy strategies for the treatment of colorectal cancer patients with liver metastases.
    Saad AM; Abdel-Rahman O
    Expert Opin Pharmacother; 2019 Oct; 20(14):1767-1775. PubMed ID: 31314604
    [No Abstract]   [Full Text] [Related]  

  • 13. Managing colorectal cancer liver metastases.
    Wagman LD; Byun TE
    Oncology (Williston Park); 2009 Nov; 23(12):1063-71. PubMed ID: 20017288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy - a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol.
    Boilève A; Maillard A; Wagner M; Dromain C; Laurent C; Dupont Bierre E; Le Sourd S; Audemar F; Ulusakarya A; Guerin-Meyer V; Smisth D; Pezzella V; De Baere T; Goere D; Gelli M; Taieb J; Boige V
    BMC Cancer; 2020 Jan; 20(1):74. PubMed ID: 32000724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research progress of conversion therapy in colorectal cancer liver metastases].
    Zhang YY; Chen SW; Wang PY; Liu YC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jan; 24(1):85-93. PubMed ID: 33461258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver only metastatic disease in patients with metastatic colorectal cancer: impact of surgery and chemotherapy.
    Padman S; Padbury R; Beeke C; Karapetis CS; Bishnoi S; Townsend AR; Maddern G; Price TJ
    Acta Oncol; 2013 Nov; 52(8):1699-706. PubMed ID: 24102180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of metastatic colorectal cancer: analysis of a consecutive series of 229 patients. The impact of a multidisciplinary approach.
    Sperti E; Faggiuolo R; Gerbino A; Magnino A; Muratore A; Ortega C; Ferraris R; Leone F; Capussotti L; Aglietta M
    Dis Colon Rectum; 2006 Oct; 49(10):1596-601. PubMed ID: 16988853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of liver metastases from colorectal cancer.
    Kemeny N
    Oncology (Williston Park); 2006 Sep; 20(10):1161-76, 1179; discussion 1179-80, 1185-6. PubMed ID: 17024869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to treat primary unresectable colorectal liver metastases.
    Vibert E; Canedo L; Adam R
    Semin Oncol; 2005 Dec; 32(6 Suppl 8):33-9. PubMed ID: 16360011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases.
    Chun YJ; Kim SG; Lee KW; Cho SH; Kim TW; Baek JY; Park YS; Hong S; Chu CW; Beom SH; Jung M; Shin SJ; Ahn JB
    Clin Colorectal Cancer; 2020 Sep; 19(3):e140-e150. PubMed ID: 32402681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.